0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Volatile Anesthetics Market Research Report 2026
Published Date: 2026-01-22
|
Report Code: QYRE-Auto-12Z20278
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Volatile Anesthetics Market Research Report 2026
BUY CHAPTERS

Global Volatile Anesthetics Market Research Report 2026

Code: QYRE-Auto-12Z20278
Report
2026-01-22
Pages:131
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Volatile Anesthetics Market Size

The global Volatile Anesthetics market was valued at US$ 1055 million in 2025 and is anticipated to reach US$ 1375 million by 2032, at a CAGR of 3.9% from 2026 to 2032.

Volatile Anesthetics Market

Volatile Anesthetics Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Volatile Anesthetics competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Volatile anesthetics are general anesthetic drugs that are administered as vapors through the lungs to induce and maintain unconsciousness during surgery and other procedures. They are liquids at room temperature (except some agents with very low boiling points that require special handling) but readily evaporate in an anesthesia machine’s vaporizer and are delivered in controlled concentrations mixed with carrier gases. After inhalation they rapidly equilibrate between the lungs, blood, and brain, allowing anesthesiologists to adjust depth of anesthesia quickly by changing the inspired concentration and ventilation. Modern volatile agents commonly used in clinical practice include sevoflurane, desflurane, and isoflurane, and their use involves balancing benefits (predictable titration and fast recovery) against risks such as dose-related cardiovascular and respiratory depression, postoperative nausea, rare malignant hyperthermia susceptibility, and the need to manage occupational exposure and environmental emissions. The product has an average price of $200-350 per kilogram and a production volume of approximately 4,000 tons per year.
Upstream for volatile anesthetics begins with basic petrochemical feedstocks that are converted into highly fluorinated/halogenated intermediates using specialty reagents (notably fluorinating and chlorinating agents), catalysts, and tightly controlled reaction and purification steps, because these products must meet very high purity and stability requirements under pharmaceutical GMP; manufacturers then distill and dry the anesthetic to specification, perform rigorous QC (impurities, water content, identity), and fill it into dedicated, moisture-tight bottles/canisters with compliant labeling and cold-chain-free but controlled logistics. Downstream, finished product moves through pharma wholesalers and hospital procurement channels to operating rooms and ambulatory surgery centers, where it is used with anesthesia machines and calibrated vaporizers (plus carrier gases) and supported by consumables and infrastructure such as breathing circuits, CO₂ absorbents, and waste-gas scavenging systems; used anesthetic largely leaves the patient via exhalation and is routed into scavenging/disposal pathways (increasingly with capture/destruction or monitoring in some facilities), while ongoing demand is driven by surgical volumes, formulary choices, and workplace exposure and environmental management practices.
The North American market for Volatile Anesthetics is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Volatile Anesthetics is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Volatile Anesthetics include Baxter, AbbVie, Piramal Critical Care, Fresenius Kabi, Halocarbon, Aspen, Pfizer, Maruishi Pharmaceutical, Jiangsu Hengrui Medicine, Lunan Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Volatile Anesthetics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Volatile Anesthetics. The Volatile Anesthetics market size, estimates, and forecasts are provided in terms of sales volume (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Volatile Anesthetics market comprehensively. Regional market sizes by Type, by Application, by MAC, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Volatile Anesthetics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Volatile Anesthetics Market Report

Report Metric Details
Report Name Volatile Anesthetics Market
Accounted market size in 2025 US$ 1055 million
Forecasted market size in 2032 US$ 1375 million
CAGR 3.9%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Heptafluoroane
  • Desflurane
  • Isoflurane
  • Others
Segment by MAC
  • Below 3%
  • Above 3%
by Application
  • Human Use
  • Animal Use
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Baxter, AbbVie, Piramal Critical Care, Fresenius Kabi, Halocarbon, Aspen, Pfizer, Maruishi Pharmaceutical, Jiangsu Hengrui Medicine, Lunan Pharmaceutical, Hikma Pharmaceuticals, HeBei YiPin Pharmaceutical, Dechra Pharmaceuticals, Life Sciences, Zhejiang AngLiKang Pharmaceutical, Linde Healthcare, Air Liquide, Messer
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by MAC, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Volatile Anesthetics manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Volatile Anesthetics sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Volatile Anesthetics Market growing?

Ans: The Volatile Anesthetics Market witnessing a CAGR of 3.9% during the forecast period 2026-2032.

What is the Volatile Anesthetics Market size in 2032?

Ans: The Volatile Anesthetics Market size in 2032 will be US$ 1375 million.

Who are the main players in the Volatile Anesthetics Market report?

Ans: The main players in the Volatile Anesthetics Market are Baxter, AbbVie, Piramal Critical Care, Fresenius Kabi, Halocarbon, Aspen, Pfizer, Maruishi Pharmaceutical, Jiangsu Hengrui Medicine, Lunan Pharmaceutical, Hikma Pharmaceuticals, HeBei YiPin Pharmaceutical, Dechra Pharmaceuticals, Life Sciences, Zhejiang AngLiKang Pharmaceutical, Linde Healthcare, Air Liquide, Messer

What are the Application segmentation covered in the Volatile Anesthetics Market report?

Ans: The Applications covered in the Volatile Anesthetics Market report are Human Use, Animal Use

What are the Type segmentation covered in the Volatile Anesthetics Market report?

Ans: The Types covered in the Volatile Anesthetics Market report are Heptafluoroane, Desflurane, Isoflurane, Others

1 Volatile Anesthetics Market Overview
1.1 Product Definition
1.2 Volatile Anesthetics by Type
1.2.1 Global Volatile Anesthetics Market Value by Type: 2025 vs 2032
1.2.2 Heptafluoroane
1.2.3 Desflurane
1.2.4 Isoflurane
1.2.5 Others
1.3 Volatile Anesthetics by MAC
1.3.1 Global Volatile Anesthetics Market Value by MAC: 2025 vs 2032
1.3.2 Below 3%
1.3.3 Above 3%
1.4 Volatile Anesthetics by Application
1.4.1 Global Volatile Anesthetics Market Value by Application: 2025 vs 2032
1.4.2 Human Use
1.4.3 Animal Use
1.5 Global Volatile Anesthetics Market Size Estimates and Forecasts
1.5.1 Global Volatile Anesthetics Revenue 2021–2032
1.5.2 Global Volatile Anesthetics Sales 2021–2032
1.5.3 Global Volatile Anesthetics Market Average Price (2021–2032)
1.6 Assumptions and Limitations
2 Volatile Anesthetics Market Competition by Manufacturers
2.1 Global Volatile Anesthetics Sales Market Share by Manufacturers (2021–2026)
2.2 Global Volatile Anesthetics Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Volatile Anesthetics Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Volatile Anesthetics, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Volatile Anesthetics, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Volatile Anesthetics, Product Types and Applications
2.7 Global Key Manufacturers of Volatile Anesthetics, Date of Entry into the Industry
2.8 Global Volatile Anesthetics Market Competitive Situation and Trends
2.8.1 Global Volatile Anesthetics Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Volatile Anesthetics Players Market Share by Revenue
2.8.3 Global Volatile Anesthetics Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Volatile Anesthetics Market Scenario by Region
3.1 Global Volatile Anesthetics Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Volatile Anesthetics Sales by Region: 2021–2032
3.2.1 Global Volatile Anesthetics Sales by Region: 2021–2026
3.2.2 Global Volatile Anesthetics Sales by Region: 2027–2032
3.3 Global Volatile Anesthetics Revenue by Region: 2021–2032
3.3.1 Global Volatile Anesthetics Revenue by Region: 2021–2026
3.3.2 Global Volatile Anesthetics Revenue by Region: 2027–2032
3.4 North America Volatile Anesthetics Market Facts & Figures by Country
3.4.1 North America Volatile Anesthetics Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Volatile Anesthetics Sales by Country (2021–2032)
3.4.3 North America Volatile Anesthetics Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Volatile Anesthetics Market Facts & Figures by Country
3.5.1 Europe Volatile Anesthetics Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Volatile Anesthetics Sales by Country (2021–2032)
3.5.3 Europe Volatile Anesthetics Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Volatile Anesthetics Market Facts & Figures by Region
3.6.1 Asia Pacific Volatile Anesthetics Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Volatile Anesthetics Sales by Region (2021–2032)
3.6.3 Asia Pacific Volatile Anesthetics Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Volatile Anesthetics Market Facts & Figures by Country
3.7.1 Latin America Volatile Anesthetics Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Volatile Anesthetics Sales by Country (2021–2032)
3.7.3 Latin America Volatile Anesthetics Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Volatile Anesthetics Market Facts & Figures by Country
3.8.1 Middle East and Africa Volatile Anesthetics Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Volatile Anesthetics Sales by Country (2021–2032)
3.8.3 Middle East and Africa Volatile Anesthetics Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Volatile Anesthetics Sales by Type (2021–2032)
4.1.1 Global Volatile Anesthetics Sales by Type (2021–2026)
4.1.2 Global Volatile Anesthetics Sales by Type (2027–2032)
4.1.3 Global Volatile Anesthetics Sales Market Share by Type (2021–2032)
4.2 Global Volatile Anesthetics Revenue by Type (2021–2032)
4.2.1 Global Volatile Anesthetics Revenue by Type (2021–2026)
4.2.2 Global Volatile Anesthetics Revenue by Type (2027–2032)
4.2.3 Global Volatile Anesthetics Revenue Market Share by Type (2021–2032)
4.3 Global Volatile Anesthetics Price by Type (2021–2032)
5 Segment by Application
5.1 Global Volatile Anesthetics Sales by Application (2021–2032)
5.1.1 Global Volatile Anesthetics Sales by Application (2021–2026)
5.1.2 Global Volatile Anesthetics Sales by Application (2027–2032)
5.1.3 Global Volatile Anesthetics Sales Market Share by Application (2021–2032)
5.2 Global Volatile Anesthetics Revenue by Application (2021–2032)
5.2.1 Global Volatile Anesthetics Revenue by Application (2021–2026)
5.2.2 Global Volatile Anesthetics Revenue by Application (2027–2032)
5.2.3 Global Volatile Anesthetics Revenue Market Share by Application (2021–2032)
5.3 Global Volatile Anesthetics Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Company Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Volatile Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Baxter Volatile Anesthetics Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 AbbVie
6.2.1 AbbVie Company Information
6.2.2 AbbVie Description and Business Overview
6.2.3 AbbVie Volatile Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 AbbVie Volatile Anesthetics Product Portfolio
6.2.5 AbbVie Recent Developments/Updates
6.3 Piramal Critical Care
6.3.1 Piramal Critical Care Company Information
6.3.2 Piramal Critical Care Description and Business Overview
6.3.3 Piramal Critical Care Volatile Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Piramal Critical Care Volatile Anesthetics Product Portfolio
6.3.5 Piramal Critical Care Recent Developments/Updates
6.4 Fresenius Kabi
6.4.1 Fresenius Kabi Company Information
6.4.2 Fresenius Kabi Description and Business Overview
6.4.3 Fresenius Kabi Volatile Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Fresenius Kabi Volatile Anesthetics Product Portfolio
6.4.5 Fresenius Kabi Recent Developments/Updates
6.5 Halocarbon
6.5.1 Halocarbon Company Information
6.5.2 Halocarbon Description and Business Overview
6.5.3 Halocarbon Volatile Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Halocarbon Volatile Anesthetics Product Portfolio
6.5.5 Halocarbon Recent Developments/Updates
6.6 Aspen
6.6.1 Aspen Company Information
6.6.2 Aspen Description and Business Overview
6.6.3 Aspen Volatile Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Aspen Volatile Anesthetics Product Portfolio
6.6.5 Aspen Recent Developments/Updates
6.7 Pfizer
6.7.1 Pfizer Company Information
6.7.2 Pfizer Description and Business Overview
6.7.3 Pfizer Volatile Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Pfizer Volatile Anesthetics Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Maruishi Pharmaceutical
6.8.1 Maruishi Pharmaceutical Company Information
6.8.2 Maruishi Pharmaceutical Description and Business Overview
6.8.3 Maruishi Pharmaceutical Volatile Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Maruishi Pharmaceutical Volatile Anesthetics Product Portfolio
6.8.5 Maruishi Pharmaceutical Recent Developments/Updates
6.9 Jiangsu Hengrui Medicine
6.9.1 Jiangsu Hengrui Medicine Company Information
6.9.2 Jiangsu Hengrui Medicine Description and Business Overview
6.9.3 Jiangsu Hengrui Medicine Volatile Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Jiangsu Hengrui Medicine Volatile Anesthetics Product Portfolio
6.9.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.10 Lunan Pharmaceutical
6.10.1 Lunan Pharmaceutical Company Information
6.10.2 Lunan Pharmaceutical Description and Business Overview
6.10.3 Lunan Pharmaceutical Volatile Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Lunan Pharmaceutical Volatile Anesthetics Product Portfolio
6.10.5 Lunan Pharmaceutical Recent Developments/Updates
6.11 Hikma Pharmaceuticals
6.11.1 Hikma Pharmaceuticals Company Information
6.11.2 Hikma Pharmaceuticals Description and Business Overview
6.11.3 Hikma Pharmaceuticals Volatile Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Hikma Pharmaceuticals Volatile Anesthetics Product Portfolio
6.11.5 Hikma Pharmaceuticals Recent Developments/Updates
6.12 HeBei YiPin Pharmaceutical
6.12.1 HeBei YiPin Pharmaceutical Company Information
6.12.2 HeBei YiPin Pharmaceutical Description and Business Overview
6.12.3 HeBei YiPin Pharmaceutical Volatile Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 HeBei YiPin Pharmaceutical Volatile Anesthetics Product Portfolio
6.12.5 HeBei YiPin Pharmaceutical Recent Developments/Updates
6.13 Dechra Pharmaceuticals
6.13.1 Dechra Pharmaceuticals Company Information
6.13.2 Dechra Pharmaceuticals Description and Business Overview
6.13.3 Dechra Pharmaceuticals Volatile Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Dechra Pharmaceuticals Volatile Anesthetics Product Portfolio
6.13.5 Dechra Pharmaceuticals Recent Developments/Updates
6.14 Life Sciences
6.14.1 Life Sciences Company Information
6.14.2 Life Sciences Description and Business Overview
6.14.3 Life Sciences Volatile Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Life Sciences Volatile Anesthetics Product Portfolio
6.14.5 Life Sciences Recent Developments/Updates
6.15 Zhejiang AngLiKang Pharmaceutical
6.15.1 Zhejiang AngLiKang Pharmaceutical Company Information
6.15.2 Zhejiang AngLiKang Pharmaceutical Description and Business Overview
6.15.3 Zhejiang AngLiKang Pharmaceutical Volatile Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Zhejiang AngLiKang Pharmaceutical Volatile Anesthetics Product Portfolio
6.15.5 Zhejiang AngLiKang Pharmaceutical Recent Developments/Updates
6.16 Linde Healthcare
6.16.1 Linde Healthcare Company Information
6.16.2 Linde Healthcare Description and Business Overview
6.16.3 Linde Healthcare Volatile Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Linde Healthcare Volatile Anesthetics Product Portfolio
6.16.5 Linde Healthcare Recent Developments/Updates
6.17 Air Liquide
6.17.1 Air Liquide Company Information
6.17.2 Air Liquide Description and Business Overview
6.17.3 Air Liquide Volatile Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Air Liquide Volatile Anesthetics Product Portfolio
6.17.5 Air Liquide Recent Developments/Updates
6.18 Messer
6.18.1 Messer Company Information
6.18.2 Messer Description and Business Overview
6.18.3 Messer Volatile Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Messer Volatile Anesthetics Product Portfolio
6.18.5 Messer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Volatile Anesthetics Industry Chain Analysis
7.2 Volatile Anesthetics Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Volatile Anesthetics Production Mode & Process Analysis
7.4 Volatile Anesthetics Sales and Marketing
7.4.1 Volatile Anesthetics Sales Channels
7.4.2 Volatile Anesthetics Distributors
7.5 Volatile Anesthetics Customer Analysis
8 Volatile Anesthetics Market Dynamics
8.1 Volatile Anesthetics Industry Trends
8.2 Volatile Anesthetics Market Drivers
8.3 Volatile Anesthetics Market Challenges
8.4 Volatile Anesthetics Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Volatile Anesthetics Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Volatile Anesthetics Market Value by MAC (US$ Million), 2025 vs 2032
 Table 3. Global Volatile Anesthetics Market Value by Application (US$ Million), 2025 vs 2032
 Table 4. Global Volatile Anesthetics Market Competitive Situation by Manufacturers in 2025
 Table 5. Global Volatile Anesthetics Sales (Tons) of Key Manufacturers (2021–2026)
 Table 6. Global Volatile Anesthetics Sales Market Share by Manufacturers (2021–2026)
 Table 7. Global Volatile Anesthetics Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 8. Global Volatile Anesthetics Revenue Share by Manufacturers (2021–2026)
 Table 9. Global Market Volatile Anesthetics Average Price (US$/kg) of Key Manufacturers (2021–2026)
 Table 10. Global Key Players of Volatile Anesthetics, Industry Ranking, 2023 vs 2024 vs 2025
 Table 11. Global Key Manufacturers of Volatile Anesthetics, Manufacturing Sites and Headquarters
 Table 12. Global Key Manufacturers of Volatile Anesthetics, Product Types and Applications
 Table 13. Global Key Manufacturers of Volatile Anesthetics, Date of Entry into the Industry
 Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Global Volatile Anesthetics Companies by Tier (Tier 1, Tier 2, Tier 3), based on Volatile Anesthetics Revenue, 2025
 Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 17. Global Volatile Anesthetics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 18. Global Volatile Anesthetics Sales by Region (Tons), 2021–2026
 Table 19. Global Volatile Anesthetics Sales Market Share by Region (2021–2026)
 Table 20. Global Volatile Anesthetics Sales by Region (Tons), 2027–2032
 Table 21. Global Volatile Anesthetics Sales Market Share by Region (2027–2032)
 Table 22. Global Volatile Anesthetics Revenue by Region (US$ Million), 2021–2026
 Table 23. Global Volatile Anesthetics Revenue Market Share by Region (2021–2026)
 Table 24. Global Volatile Anesthetics Revenue by Region (US$ Million), 2027–2032
 Table 25. Global Volatile Anesthetics Revenue Market Share by Region (2027–2032)
 Table 26. North America Volatile Anesthetics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 27. North America Volatile Anesthetics Sales by Country (Tons), 2021–2026
 Table 28. North America Volatile Anesthetics Sales by Country (Tons), 2027–2032
 Table 29. North America Volatile Anesthetics Revenue by Country (US$ Million), 2021–2026
 Table 30. North America Volatile Anesthetics Revenue by Country (US$ Million), 2027–2032
 Table 31. Europe Volatile Anesthetics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 32. Europe Volatile Anesthetics Sales by Country (Tons), 2021–2026
 Table 33. Europe Volatile Anesthetics Sales by Country (Tons), 2027–2032
 Table 34. Europe Volatile Anesthetics Revenue by Country (US$ Million), 2021–2026
 Table 35. Europe Volatile Anesthetics Revenue by Country (US$ Million), 2027–2032
 Table 36. Asia Pacific Volatile Anesthetics Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 37. Asia Pacific Volatile Anesthetics Sales by Region (Tons), 2021–2026
 Table 38. Asia Pacific Volatile Anesthetics Sales by Region (Tons), 2027–2032
 Table 39. Asia Pacific Volatile Anesthetics Revenue by Region (US$ Million), 2021–2026
 Table 40. Asia Pacific Volatile Anesthetics Revenue by Region (US$ Million), 2027–2032
 Table 41. Latin America Volatile Anesthetics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 42. Latin America Volatile Anesthetics Sales by Country (Tons), 2021–2026
 Table 43. Latin America Volatile Anesthetics Sales by Country (Tons), 2027–2032
 Table 44. Latin America Volatile Anesthetics Revenue by Country (US$ Million), 2021–2026
 Table 45. Latin America Volatile Anesthetics Revenue by Country (US$ Million), 2027–2032
 Table 46. Middle East and Africa Volatile Anesthetics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 47. Middle East and Africa Volatile Anesthetics Sales by Country (Tons), 2021–2026
 Table 48. Middle East and Africa Volatile Anesthetics Sales by Country (Tons), 2027–2032
 Table 49. Middle East and Africa Volatile Anesthetics Revenue by Country (US$ Million), 2021–2026
 Table 50. Middle East and Africa Volatile Anesthetics Revenue by Country (US$ Million), 2027–2032
 Table 51. Global Volatile Anesthetics Sales (Tons) by Type (2021–2026)
 Table 52. Global Volatile Anesthetics Sales (Tons) by Type (2027–2032)
 Table 53. Global Volatile Anesthetics Sales Market Share by Type (2021–2026)
 Table 54. Global Volatile Anesthetics Sales Market Share by Type (2027–2032)
 Table 55. Global Volatile Anesthetics Revenue (US$ Million) by Type (2021–2026)
 Table 56. Global Volatile Anesthetics Revenue (US$ Million) by Type (2027–2032)
 Table 57. Global Volatile Anesthetics Revenue Market Share by Type (2021–2026)
 Table 58. Global Volatile Anesthetics Revenue Market Share by Type (2027–2032)
 Table 59. Global Volatile Anesthetics Price (US$/kg) by Type (2021–2026)
 Table 60. Global Volatile Anesthetics Price (US$/kg) by Type (2027–2032)
 Table 61. Global Volatile Anesthetics Sales (Tons) by Application (2021–2026)
 Table 62. Global Volatile Anesthetics Sales (Tons) by Application (2027–2032)
 Table 63. Global Volatile Anesthetics Sales Market Share by Application (2021–2026)
 Table 64. Global Volatile Anesthetics Sales Market Share by Application (2027–2032)
 Table 65. Global Volatile Anesthetics Revenue (US$ Million) by Application (2021–2026)
 Table 66. Global Volatile Anesthetics Revenue (US$ Million) by Application (2027–2032)
 Table 67. Global Volatile Anesthetics Revenue Market Share by Application (2021–2026)
 Table 68. Global Volatile Anesthetics Revenue Market Share by Application (2027–2032)
 Table 69. Global Volatile Anesthetics Price (US$/kg) by Application (2021–2026)
 Table 70. Global Volatile Anesthetics Price (US$/kg) by Application (2027–2032)
 Table 71. Baxter Company Information
 Table 72. Baxter Description and Business Overview
 Table 73. Baxter Volatile Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 74. Baxter Volatile Anesthetics Product
 Table 75. Baxter Recent Developments/Updates
 Table 76. AbbVie Company Information
 Table 77. AbbVie Description and Business Overview
 Table 78. AbbVie Volatile Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 79. AbbVie Volatile Anesthetics Product
 Table 80. AbbVie Recent Developments/Updates
 Table 81. Piramal Critical Care Company Information
 Table 82. Piramal Critical Care Description and Business Overview
 Table 83. Piramal Critical Care Volatile Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 84. Piramal Critical Care Volatile Anesthetics Product
 Table 85. Piramal Critical Care Recent Developments/Updates
 Table 86. Fresenius Kabi Company Information
 Table 87. Fresenius Kabi Description and Business Overview
 Table 88. Fresenius Kabi Volatile Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 89. Fresenius Kabi Volatile Anesthetics Product
 Table 90. Fresenius Kabi Recent Developments/Updates
 Table 91. Halocarbon Company Information
 Table 92. Halocarbon Description and Business Overview
 Table 93. Halocarbon Volatile Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 94. Halocarbon Volatile Anesthetics Product
 Table 95. Halocarbon Recent Developments/Updates
 Table 96. Aspen Company Information
 Table 97. Aspen Description and Business Overview
 Table 98. Aspen Volatile Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 99. Aspen Volatile Anesthetics Product
 Table 100. Aspen Recent Developments/Updates
 Table 101. Pfizer Company Information
 Table 102. Pfizer Description and Business Overview
 Table 103. Pfizer Volatile Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 104. Pfizer Volatile Anesthetics Product
 Table 105. Pfizer Recent Developments/Updates
 Table 106. Maruishi Pharmaceutical Company Information
 Table 107. Maruishi Pharmaceutical Description and Business Overview
 Table 108. Maruishi Pharmaceutical Volatile Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 109. Maruishi Pharmaceutical Volatile Anesthetics Product
 Table 110. Maruishi Pharmaceutical Recent Developments/Updates
 Table 111. Jiangsu Hengrui Medicine Company Information
 Table 112. Jiangsu Hengrui Medicine Description and Business Overview
 Table 113. Jiangsu Hengrui Medicine Volatile Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 114. Jiangsu Hengrui Medicine Volatile Anesthetics Product
 Table 115. Jiangsu Hengrui Medicine Recent Developments/Updates
 Table 116. Lunan Pharmaceutical Company Information
 Table 117. Lunan Pharmaceutical Description and Business Overview
 Table 118. Lunan Pharmaceutical Volatile Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 119. Lunan Pharmaceutical Volatile Anesthetics Product
 Table 120. Lunan Pharmaceutical Recent Developments/Updates
 Table 121. Hikma Pharmaceuticals Company Information
 Table 122. Hikma Pharmaceuticals Description and Business Overview
 Table 123. Hikma Pharmaceuticals Volatile Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 124. Hikma Pharmaceuticals Volatile Anesthetics Product
 Table 125. Hikma Pharmaceuticals Recent Developments/Updates
 Table 126. HeBei YiPin Pharmaceutical Company Information
 Table 127. HeBei YiPin Pharmaceutical Description and Business Overview
 Table 128. HeBei YiPin Pharmaceutical Volatile Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 129. HeBei YiPin Pharmaceutical Volatile Anesthetics Product
 Table 130. HeBei YiPin Pharmaceutical Recent Developments/Updates
 Table 131. Dechra Pharmaceuticals Company Information
 Table 132. Dechra Pharmaceuticals Description and Business Overview
 Table 133. Dechra Pharmaceuticals Volatile Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 134. Dechra Pharmaceuticals Volatile Anesthetics Product
 Table 135. Dechra Pharmaceuticals Recent Developments/Updates
 Table 136. Life Sciences Company Information
 Table 137. Life Sciences Description and Business Overview
 Table 138. Life Sciences Volatile Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 139. Life Sciences Volatile Anesthetics Product
 Table 140. Life Sciences Recent Developments/Updates
 Table 141. Zhejiang AngLiKang Pharmaceutical Company Information
 Table 142. Zhejiang AngLiKang Pharmaceutical Description and Business Overview
 Table 143. Zhejiang AngLiKang Pharmaceutical Volatile Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 144. Zhejiang AngLiKang Pharmaceutical Volatile Anesthetics Product
 Table 145. Zhejiang AngLiKang Pharmaceutical Recent Developments/Updates
 Table 146. Linde Healthcare Company Information
 Table 147. Linde Healthcare Description and Business Overview
 Table 148. Linde Healthcare Volatile Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 149. Linde Healthcare Volatile Anesthetics Product
 Table 150. Linde Healthcare Recent Developments/Updates
 Table 151. Air Liquide Company Information
 Table 152. Air Liquide Description and Business Overview
 Table 153. Air Liquide Volatile Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 154. Air Liquide Volatile Anesthetics Product
 Table 155. Air Liquide Recent Developments/Updates
 Table 156. Messer Company Information
 Table 157. Messer Description and Business Overview
 Table 158. Messer Volatile Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 159. Messer Volatile Anesthetics Product
 Table 160. Messer Recent Developments/Updates
 Table 161. Key Raw Materials Lists
 Table 162. Raw Materials Key Suppliers Lists
 Table 163. Volatile Anesthetics Distributors List
 Table 164. Volatile Anesthetics Customers List
 Table 165. Volatile Anesthetics Market Trends
 Table 166. Volatile Anesthetics Market Drivers
 Table 167. Volatile Anesthetics Market Challenges
 Table 168. Volatile Anesthetics Market Restraints
 Table 169. Research Programs/Design for This Report
 Table 170. Key Data Information from Secondary Sources
 Table 171. Key Data Information from Primary Sources
 Table 172. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Volatile Anesthetics
 Figure 2. Global Volatile Anesthetics Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Volatile Anesthetics Market Share by Type: 2025 & 2032
 Figure 4. Heptafluoroane Product Picture
 Figure 5. Desflurane Product Picture
 Figure 6. Isoflurane Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Volatile Anesthetics Market Value by MAC (US$ Million), 2021–2032
 Figure 9. Global Volatile Anesthetics Market Share by MAC: 2025 vs 2032
 Figure 10. Below 3% Product Picture
 Figure 11. Above 3% Product Picture
 Figure 12. Global Volatile Anesthetics Market Value by Application (US$ Million), 2021–2032
 Figure 13. Global Volatile Anesthetics Market Share by Application: 2025 & 2032
 Figure 14. Human Use
 Figure 15. Animal Use
 Figure 16. Global Volatile Anesthetics Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 17. Global Volatile Anesthetics Market Size (US$ Million), 2021–2032
 Figure 18. Global Volatile Anesthetics Sales (Tons), 2021–2032
 Figure 19. Global Volatile Anesthetics Average Price (US$/kg), 2021–2032
 Figure 20. Volatile Anesthetics Report Years Considered
 Figure 21. Volatile Anesthetics Sales Share by Manufacturers in 2025
 Figure 22. Global Volatile Anesthetics Revenue Share by Manufacturers in 2025
 Figure 23. Top 5 and Top 10 Global Volatile Anesthetics Players: Market Share by Revenue in Volatile Anesthetics in 2025
 Figure 24. Volatile Anesthetics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 25. Global Volatile Anesthetics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 26. North America Volatile Anesthetics Sales Market Share by Country (2021–2032)
 Figure 27. North America Volatile Anesthetics Revenue Market Share by Country (2021–2032)
 Figure 28. United States Volatile Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Canada Volatile Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Europe Volatile Anesthetics Sales Market Share by Country (2021–2032)
 Figure 31. Europe Volatile Anesthetics Revenue Market Share by Country (2021–2032)
 Figure 32. Germany Volatile Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. France Volatile Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. U.K. Volatile Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Italy Volatile Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Russia Volatile Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Asia Pacific Volatile Anesthetics Sales Market Share by Region (2021–2032)
 Figure 38. Asia Pacific Volatile Anesthetics Revenue Market Share by Region (2021–2032)
 Figure 39. China Volatile Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Japan Volatile Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. South Korea Volatile Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. India Volatile Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Australia Volatile Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. China Taiwan Volatile Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Southeast Asia Volatile Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Latin America Volatile Anesthetics Sales Market Share by Country (2021–2032)
 Figure 47. Latin America Volatile Anesthetics Revenue Market Share by Country (2021–2032)
 Figure 48. Mexico Volatile Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Brazil Volatile Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Argentina Volatile Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Colombia Volatile Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Middle East and Africa Volatile Anesthetics Sales Market Share by Country (2021–2032)
 Figure 53. Middle East and Africa Volatile Anesthetics Revenue Market Share by Country (2021–2032)
 Figure 54. Turkey Volatile Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Saudi Arabia Volatile Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. UAE Volatile Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 57. Global Sales Market Share of Volatile Anesthetics by Type (2021–2032)
 Figure 58. Global Revenue Market Share of Volatile Anesthetics by Type (2021–2032)
 Figure 59. Global Volatile Anesthetics Price (US$/kg) by Type (2021–2032)
 Figure 60. Global Sales Market Share of Volatile Anesthetics by Application (2021–2032)
 Figure 61. Global Revenue Market Share of Volatile Anesthetics by Application (2021–2032)
 Figure 62. Global Volatile Anesthetics Price (US$/kg) by Application (2021–2032)
 Figure 63. Volatile Anesthetics Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS